Staining solution for cataract surgeries available as vial and syringe
Industry updates


Colin Kerr
Published: Sunday, January 1, 2017
[caption id="attachment_6216" align="alignnone" width="750"]
Vioron staining solution[/caption]
STAINING SOLUTION
Vioron is Geuder’s number one tissue staining solution for cataract surgeries, and is available as vial and syringe.“It consists of trypan blue and ensures an effective staining and thus brilliant visualisation of the anterior lens capsule,” said a company spokesman.
“This staining solution enables an excellent distinction of the capsulorhexis margin. It is quick and easy to apply, and applicable to a variety of further indications, e.g. congenital or (hyper) mature cataract surgery,” added the spokesman.
www.geuder.com
EXPANDED CUSTOMER REACH
HOYA has announced a definitive agreement to acquire Performance Optics, including its subsidiaries VISION EASE and Daemyung Optical. Performance Optics is a global ophthalmic lens manufacturer specialising in polycarbonate, photochromic, polarised and high-index eyeglass lenses.
“The acquisition of Performance Optics expands HOYA’s customer reach, particularly through VISION EASE’s presence in the Americas and its strengths in polycarbonate products and technologies,” said Girts Cimermans, CEO of HOYA Vision Care. “Performance Optics provides HOYA with additional capabilities,” he added.
www.hoya.com
NEW APPOINTMENT
Carl Zeiss Meditec has appointed Steven C Schallhorn MD as Chief Medical Officer for Global Ophthalmic Devices, consisting of refractive lasers, surgical ophthalmology and ophthalmic diagnostics.
Dr Schallhorn will serve on the Executive Leadership Team, providing strategic direction for the business and medical guidance on the clinical use of ZEISS’ portfolio of ophthalmic diagnostic and surgical technologies. The company said Dr Schallhorn will collaborate with key opinion leaders.

Tags: industry, new products, product updates
Latest Articles
Organising for Success
Professional and personal goals drive practice ownership and operational choices.
Update on Astigmatism Analysis
Is Frugal Innovation Possible in Ophthalmology?
Improving access through financially and environmentally sustainable innovation.
iNovation Innovators Den Boosts Eye Care Pioneers
New ideas and industry, colleague, and funding contacts among the benefits.
José Güell: Trends in Cornea Treatment
Endothelial damage, cellular treatments, human tissue, and infections are key concerns on the horizon.
Making IOLs a More Personal Choice
Surgeons may prefer some IOLs for their patients, but what about for themselves?
Need to Know: Higher-Order Aberrations and Polynomials
This first instalment in a tutorial series will discuss more on the measurement and clinical implications of HOAs.
Never Go In Blind
Novel ophthalmic block simulator promises higher rates of confidence and competence in trainees.
Simulators Benefit Surgeons and Patients
Helping young surgeons build confidence and expertise.